pe
pep-05440 v1 CC-BY-SA-4.0

At1g10310 antiviral peptide

A short protein fragment studied for fighting viruses; experimental, not an approved drug.

statusbioassayed targetANTIMICROBIAL length44 aa refs1
antiviral
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.488
avg pLDDT71.1
ranking score0.666
STRUCTURE · PEP-05440 × ANTIMICROBIAL
ranking0.666
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence44 aa
151015202530354044
KVSGGEAVAAI GICATASAAIG GLAGATLVTPY CVGTWGLIRSH
in the news 6 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.6663135886192322 boltz-2
3-letter notation
Lys-Val-Ser-Gly-Gly-Glu-Ala-Val-Ala-Ala-Ile-Gly-Ile-Cys-Ala-Thr-Ala-Ser-Ala-Ala-Ile-Gly-Gly-Leu-Ala-Gly-Ala-Thr-Leu-Val-Thr-Pro-Tyr-Cys-Val-Gly-Thr-Trp-Gly-Leu-Ile-Arg-Ser-His
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). At1g10310 antiviral peptide (pep-05440, v1). PeptideModel. https://peptidemodel.com/card/pep-05440
@peptide{pep05440,
  sequence = {KVSGGEAVAAIGICATASAAIGGLAGATLVTPYCVGTWGLIRSH},
  target   = {antimicrobial},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
references 1 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use